SCHEMBL6805822

SCHEMBL6805822

COc1ccccc1S(=O)(=O)c1ccc(C[C@@H](C)N)cc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.60
SLC6A4 P31645 2/20 0.47
ABCC9 O60706 1/20 0.47
ABCC8 Q09428 1/20 0.47
KCNJ11 Q14654 1/20 0.47
KCNJ8 Q15842 1/20 0.47
ITGB1 P05556 1/20 0.45
ITGA4 P13612 1/20 0.45
SLC6A2 P23975 2/20 0.45
TAAR1 Q96RJ0 2/20 0.45
MAOA P21397 1/20 0.45
SLC6A3 Q01959 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
CYP2A6 P11509 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
NAMPT P43490 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798547 0.80 HTR6 (0.56) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL10775490 0.78 TAAR1 (0.55) SLC6A4SLC6A2TAAR1MAOASLC6A3
SCHEMBL6540600 0.78 SLC6A4 (0.74) SLC6A4TAAR1
SCHEMBL8865817 0.77 HTR6 (0.74) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL6913555 0.77 HTR6 (1.00) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL28541778 0.76 HTR6 (0.77) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL931939 0.76 HTR6 (0.77) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL7176841 0.74 HTR6 (0.74) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL31352974 0.73 HTR6 (0.77) HTR6ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL1412238 0.72 ADRA1D (0.55) SLC6A4TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 HTR6 689/4885SLC6A4 2109/4885ABCC9 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.